| Line item | 2025-12-31 FY | 2025-11-24 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | $3.33M | $68.61K |
| R&D | – | – | – | – | – | – |
| SG&A | $1.95M | $102.13K | $1.43M | $2.02M | $3.13M | $7.87K |
| Operating Income | -$2.04M | – | -$1.58M | -$2.22M | – | – |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | $38.69K | – | $125.95K | – | $180.69K | – |
| Net Income | -$1.79M | – | -$899.93K | -$54.32K | -$2.39M | -$68.60K |
| EPS (basic) | – | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – | – |